Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
99.30    0.40 (0.40%)
Bid:
99.30
Ask:
99.34
Spread: 0.04 (0.04%)
Market Cap: £57.87b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Final Terms

14 Apr 2026 16:00

RNS Number : 4561A
Lloyds Banking Group PLC
14 April 2026
 

14 April 2026

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 14 April 2026, for the £500,000,000 5.625 per cent. Fixed Rate Reset Dated Subordinated Tier 2 Notes due 2036 (the "Final Terms") (the "Notes") issued by Lloyds Banking Group plc pursuant to the base prospectus dated 23 March 2026 which constitutes a base prospectus (the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of the PRM.

The expression "PRM" means the FCA Handbook Prospectus Rules: Admission to Trading on a Regulated Market sourcebook.

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/4561A_1-2026-4-14.pdf

A copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations DirectorTel: +44 (0) 20 7356 1571Email: douglas.radcliffe@lloydsbanking.com 

Group Corporate Affairs:

Matt SmithHead of Media RelationsTel: +44 (0) 7788 352 487Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in the Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II/UK MiFIR (Product Governance) - professionals and ECPs-only / No EU PRIIPs KID or UK PRIIPs KID/CCI product summary - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs key information document (KID) or UK PRIIPs key information document (KID)/CCI product summary (as defined in the FCA Product Disclosure Sourcebook (DISC)) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTUSVSRNWUSAAR
Date   Source Headline
29th Feb 20245:18 pmRNSTotal Voting Rights
29th Feb 20244:21 pmRNS2023 Form 20F Filed
29th Feb 20242:30 pmRNSTotal Voting Rights
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
28th Feb 20245:57 pmRNSTransaction in Own Shares
27th Feb 20245:59 pmRNSTransaction in Own Shares
26th Feb 20246:15 pmRNSTransaction in Own Shares
26th Feb 202411:00 amRNSDirector/PDMR Shareholding
23rd Feb 20246:10 pmRNSTransaction in Own Shares
23rd Feb 202411:50 amRNSPublication of Suppl.Prospcts
23rd Feb 20247:34 amRNSShare Buyback Programme Commences
22nd Feb 20244:13 pmRNS2023 Form 20F Filed
22nd Feb 20247:00 amRNSBoard Changes
22nd Feb 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNS2023 Annual Report and Accounts
20th Feb 20242:05 pmRNSReplacement Block listing Interim Review
20th Feb 20242:00 pmRNSReplacement Block listing Interim Review
15th Feb 20247:00 amRNSBoard Change
31st Jan 20243:56 pmRNSTotal Voting Rights
25th Jan 20245:07 pmRNSBoard Committee Change
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
5th Jan 20241:50 pmRNSPublication of Final Terms
2nd Jan 202412:00 pmRNSBlock listing Interim Review
29th Dec 202310:30 amRNSTotal Voting Rights
18th Dec 20232:30 pmRNSBoard Committee Change
18th Dec 20232:00 pmRNSDirector/PDMR Shareholding
12th Dec 20234:00 pmRNSDirector/PDMR Shareholding
30th Nov 20232:00 pmRNSTotal Voting Rights
20th Nov 20232:00 pmRNSBlock Listing of Shares
10th Nov 20234:00 pmRNSDirector/PDMR Shareholding
6th Nov 20233:57 pmRNSPublication of Final Terms
31st Oct 202311:20 amRNSTotal Voting Rights
26th Oct 20233:47 pmRNSPublication of Suppl.Prospcts
26th Oct 20231:02 pmRNSPublication of Suppl.Prospcts
26th Oct 202312:59 pmRNSPublication of Suppl.Prospcts - Correction
25th Oct 202312:09 pmRNSPublication of Suppl.Prospcts
25th Oct 202311:57 amRNS2023 Q3 Interim Management Statement
25th Oct 20237:00 amRNS2023 Q3 Interim Management Statement
11th Oct 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20231:28 pmRNSPublication of Final Terms
20th Sep 20232:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20232:00 pmRNSBoard and Committee changes
13th Sep 20231:45 pmRNSDirector/PDMR Shareholding
13th Sep 20239:20 amRNS2023 Half-Year Results
31st Aug 202312:00 pmRNSTotal Voting Rights
29th Aug 20237:21 amRNSCompletion of £2 billion Share Buyback Programme
25th Aug 20235:51 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.